LY-2886721 - CAS# 1262036-50-9 60228 InChi: InChI=1S/C22H12Cl4N2O4/c23-17-7-3-13(9-19(17)25)1-5-15-11-16(22(28(31)32)12-21(15)27(29)30)6-2-14-4-8-18(24)20(26)10-14/h1-12H/b5-1+

InChi: InChI=1S/C22H12Cl4N2O4/c23-17-7-3-13(9-19(17)25)1-5-15-11-16(22(28(31)32)12-21(15)27(29)30)6-2-14-4-8-18(24)20(26)10-14/h1-12H/b5-1+

5-bis(4-nitrobenzylidene)piperidin-4-one

Smiles: O=C1C=C(OC2=C1C=CC=C2C1C=CC=CC=1)N1CCOCC1

Acalabrutinib (100 mg twice per day) assessed for thrombus formation at injured arterioles of the mice

HS Tariff Code: 2934

LY-2886721 - CAS# 1262036-50-9 60228 InChi: InChI=1S/C22H12Cl4N2O4/c23-17-7-3-13(9-19(17)25)1-5-15-11-16(22(28(31)32)12-21(15)27(29)30)6-2-14-4-8-18(24)20(26)10-14/h1-12H/b5-1+LY2886721, CAS No. 1262036 50 9, is an BACE inhibitor used for the treatment of Alzheimer's Disease. IC50 value: Target: BACE LY2886721 is a novel potent agent that is used to treat Alzheimers Disease in preclinical experiments. LY2886721 is under clinical study. A Safety Study of LY2886721 Multiple Doses is performing in Healthy Subjects. Product information CAS Number: 1262036 50 9 Molecular Weight: 390. 41 Formula: C18H16F2N4O2S Chemical Name: N (3